Andere talen Amarin Corporation plc

Aandelen

AMRN

US0231112063

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,8749 ^USD	+1,72%		+1,82%	+0,56%

19/04	Europese aandelen verhandeld in VS als American Depositary Receipts trend hoger in vrijdaghandel, maar eindigen week lager	MT
18/04	Europese aandelen verhandeld in de VS als American Depositary Receipts vlak in de donderdaghandel	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event	24/04
Amarin Announces Results of Annual General Meeting of Shareholders	22/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	19/04
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	18/04
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	17/04
Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024	15/04
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	12/04
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	10/04
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	09/04
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24	08/04
New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups	08/04
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups	06/04
Amarin Corporation plc Announces New Reduce-It® Analyses Show Vascepa®/Vazkepa® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups	06/04
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups	06/04
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	05/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	04/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading	03/04
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe	03/04
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe	03/04
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading	02/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Amarin Corporation plc

Aandelen

AMRN

US0231112063

Andere talen

Filters